Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial

AIMS/HYPOTHESIS: We aimed to determine the persistence of glycaemic control 1 year after a limited period of intensive glycaemic management of type 2 diabetes. METHODS: 4119 ACCORD Trial participants randomized to target HbA(1c) <6.0% (42 mmol/mol) for 4.0±1.2 years were systematically transition...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Diabetologia
Главные авторы: Punthakee, Zubin, Miller, Michael E., Simmons, Debra L., Riddle, Matthew C., Ismail-Beigi, Faramarz, Brillon, David J., Bergenstal, Richard M., Savage, Peter J., Hramiak, Irene, Largay, Joseph F., Sood, Ajay, Gerstein, Hertzel C.
Формат: Artigo
Язык:Inglês
Опубликовано: 2014
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698982/
https://ncbi.nlm.nih.gov/pubmed/24985147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-014-3318-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы